Synthetic Biologics (SYN) Reports 2016 EPS of ($0.29)

Synthetic Biologics (NYSE: SYN) reported 2016 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c